China Pharma Holdings, Inc. (CPHI) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 983.54K | 1.23M | 756.22K | 1.03M | 1.14M | 1.13M | 1.1M | 924.94K | 1.37M | 2.15M | 1.8M | 1.1M |
| Revenue Growth % | -13.44% | 8.11% | -31.26% | 10.9% | -17.05% | -47.25% | -39% | -15.75% | -30.12% | -26.41% | -8.26% | -31.94% |
| Cost of Goods Sold | 1.52M | 1.08M | 815.87K | 1.11M | 1.27M | 1.19M | 1.62M | 2.05M | 1.66M | 2.23M | 2.04M | 1.24M |
| COGS % of Revenue | 154.88% | 87.7% | 107.89% | 108.48% | 111.97% | 104.91% | 147.23% | 221.12% | 121.17% | 103.68% | 112.93% | 113.36% |
| Gross Profit | -539.79K | 150.78K | -59.65K | -87.01K | -136.06K | -55.67K | -519.65K | -1.12M | -290.02K | -79.16K | -233.19K | -146.66K |
| Gross Margin % | -54.88% | 12.3% | -7.89% | -8.48% | -11.97% | -4.91% | -47.23% | -121.12% | -21.17% | -3.68% | -12.93% | -13.36% |
| Gross Profit Growth % | -296.73% | 370.85% | 88.52% | 92.23% | 53.09% | 29.68% | -122.84% | -663.88% | -263% | -285.46% | -69.28% | 36.06% |
| Operating Expenses | 577.47K | 1.35M | 568.49K | 565.11K | 622.56K | 1.14M | 565.61K | 271.21K | 626.03K | 1.11M | 480.35K | 309.65K |
| OpEx % of Revenue | 58.71% | 110.24% | 75.18% | 55.09% | 54.79% | 100.56% | 51.41% | 29.32% | 45.7% | 51.42% | 26.63% | 28.2% |
| Selling, General & Admin | 493.71K | 1.19M | 502.87K | 542.13K | 594.29K | 1.03M | 479.65K | 203.32K | 596.64K | 949.34K | 452.79K | 281.85K |
| SG&A % of Revenue | 50.2% | 96.9% | 66.5% | 52.85% | 52.3% | 91.18% | 43.6% | 21.98% | 43.56% | 44.16% | 25.11% | 25.67% |
| Research & Development | 83.76K | 190.04K | 40.32K | 20.95K | 29.59K | 547 | 87.61K | 164.33K | 31.45K | 147.55K | 45.77K | 23.75K |
| R&D % of Revenue | 8.52% | 15.5% | 5.33% | 2.04% | 2.6% | 0.05% | 7.96% | 17.77% | 2.3% | 6.86% | 2.54% | 2.16% |
| Other Operating Expenses | 0 | -26.46K | 25.3K | 2.03K | -1.32K | 105.87K | -1.66K | -96.45K | -2.07K | 8.44K | -18.21K | 4.05K |
| Operating Income | -1.12M | -1.2M | -628.14K | -652.12K | -758.62K | -1.2M | -1.09M | -1.39M | -916.05K | -1.18M | -713.54K | -456.31K |
| Operating Margin % | -113.6% | -97.9% | -83.06% | -63.57% | -66.76% | -105.47% | -98.65% | -150.44% | -66.87% | -55.1% | -39.57% | -41.56% |
| Operating Income Growth % | -47.28% | -0.35% | 42.12% | 53.14% | 17.19% | -0.97% | -52.09% | -204.95% | -130.47% | -1.32% | -3.61% | 41.47% |
| EBITDA | -136.69K | -702.77K | -272.11K | -331.26K | -429.31K | -747.96K | -388.31K | -649.88K | -182.25K | -488.66K | -30.45K | 238.53K |
| EBITDA Margin % | -13.9% | -57.32% | -35.98% | -32.29% | -37.78% | -65.96% | -35.3% | -70.26% | -13.3% | -22.73% | -1.69% | 21.73% |
| EBITDA Growth % | 68.16% | 6.04% | 29.92% | 49.03% | -135.55% | -53.07% | -1175.33% | -372.45% | -164.54% | 7.73% | -25.21% | 347.5% |
| D&A (Non-Cash Add-back) | 980.57K | 497.43K | 356.03K | 320.86K | 329.31K | 448.07K | 696.94K | 741.64K | 733.8K | 695.84K | 683.09K | 694.84K |
| EBIT | -1.12M | -1.2M | -627.44K | -501.01K | -757.54K | -1.19M | -1.08M | -1.39M | -913.74K | -1.18M | -711.36K | -455.37K |
| Net Interest Income | -25.88K | -22.39K | -23.75K | -26.94K | -26.95K | -28.4K | -32.65K | -46.61K | -39.84K | -47.72K | -64.06K | -136.72K |
| Interest Income | 147 | 213 | 294 | 422 | 1.07K | 1.33K | 1.46K | 1.53K | 2.31K | 2.53K | 2.18K | 942 |
| Interest Expense | 26.03K | 22.6K | 24.05K | 27.36K | 28.03K | 29.73K | 34.11K | 48.14K | 42.16K | 50.25K | 66.24K | 137.66K |
| Other Income/Expense | -25.88K | -21.94K | -23.34K | 123.75K | -26.95K | -28.4K | -32.65K | -46.61K | -39.84K | -47.72K | -64.06K | -136.72K |
| Pretax Income | -1.14M | -1.22M | -651.48K | -528.37K | -785.57K | -1.22M | -1.12M | -1.44M | -955.89K | -1.23M | -777.6K | -593.03K |
| Pretax Margin % | -116.23% | -99.69% | -86.15% | -51.51% | -69.14% | -107.98% | -101.61% | -155.48% | -69.78% | -57.32% | -43.12% | -54.02% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -1.14M | -1.22M | -651.48K | -528.37K | -785.57K | -1.22M | -1.12M | -1.44M | -955.89K | -1.23M | -777.6K | -593.03K |
| Net Margin % | -116.23% | -99.69% | -86.15% | -51.51% | -69.14% | -107.98% | -101.61% | -155.48% | -69.78% | -57.32% | -43.12% | -54.02% |
| Net Income Growth % | -45.52% | 0.19% | 41.72% | 63.26% | 17.82% | 0.63% | -43.76% | -142.51% | -100.83% | 2.53% | 1.67% | 33.25% |
| Net Income (Continuing) | -1.14M | -1.22M | -651.48K | -528.37K | -785.57K | -1.22M | -1.12M | -1.44M | -955.89K | -1.23M | -777.6K | -593.03K |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.27 | -0.23 | -0.17 | -0.16 | -0.18 | -0.26 | -0.23 | -0.30 | -0.20 | -0.26 | -0.16 | -0.12 |
| EPS Growth % | -50% | 11.54% | 26.09% | 46.67% | 10% | 0% | -43.75% | -150% | -100% | -23.81% | 79.75% | 76% |
| EPS (Basic) | -0.27 | -0.23 | -0.17 | -0.16 | -0.18 | -0.26 | -0.23 | -0.30 | -0.20 | -0.26 | -0.16 | -0.12 |
| Diluted Shares Outstanding | 4.29M | 4.29M | 3.87M | 3.26M | 4.26M | 4.76M | 4.76M | 4.76M | 4.76M | 4.76M | 4.76M | 4.76M |
| Basic Shares Outstanding | 4.29M | 4.29M | 3.87M | 3.26M | 4.26M | 4.76M | 4.76M | 4.76M | 4.76M | 4.76M | 4.76M | 4.76M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |